Biotherapeutics Discovery.
End-to-End.
Genedata Biologics® streamlines the discovery of biotherapeutics — including bispecifics, ADCs, TCRs, CAR-Ts, and AAVs. As the industry’s most widely adopted platform, it integrates end-to-end workflows and automates routine tasks, empowering teams to focus on scientific innovation.
Our Customers
One of the reasons we chose Genedata Biologics was the platform’s process coverage. We required that the full diversity of Pfizer’s large-molecule processes and technologies be supported by one integrated system.
We decided to work with Genedata Biologics because it meets our requirements across all phases of biologics discovery, including novel multi-specific antibody formats and innovative automation methods.
Simon Chell, Ph.D.
Vice President of Biologics Engineering
Genedata Biologics gives all our R&D groups a central place to record and access TCR-related information in real time, along the end-to-end workflow.
We are excited to implement the Genedata Biopharma Platform as a central integrated data backbone to streamline the capture, integration, democratization, and analysis of increasingly complex and diverse data types across Genmab’s discovery and clinical workflows.
We undertook a thorough selection process to find the best antibody workflow platform and Genedata Biologics was the obvious choice.
Genedata Biologics was the clear choice as a backbone system to support the full diversity of our complex and rapidly evolving antibody discovery processes.
Genedata seamlessly integrates into an existing research informatics environment and supports the full process through automation, standardization, and integration.
The Genedata platform is the core knowledge management system for our global Biologics Engineering organization, helping us to streamline our research with the aim of developing novel therapies, faster.
Simon Chell, Ph.D.
Vice President of Biologics Engineering
Genedata Biologics was the obvious choice because it is a proven, off-the-shelf enterprise platform that can be rapidly deployed across our organization.
A commercial data management solution such as this has been sorely lacking in protein therapeutics.
We appreciate Genedata Biologics’ flexible business model, which made it possible for a company of our size to adopt a market-leading platform solution.
Genedata Biologics will be our central repository for mission-critical data on therapeutic candidates such as bioactivity, developability, and manufacturability, and will enable transparent decision-making on candidates to move forward.
Genedata Biologics Applications
Advancing Bispecific Antibody Discovery
Optimize bispecific antibody discovery and automate downstream processes, including expression, purification, and characterization, to significantly boost throughput.
Genedata Biologics identifies optimal antigen binder combinations and formats, helping resolve key bottlenecks and enabling the systematic design, cloning, and testing of large panels of bi- and multi-specific antibodies, such as knobs-into-holes (KinH), Fab-scFv, IgG-scFv, DuoBody, DVD-Ig, tandem-scFv-Fc, and their parametric variants (e.g., linkers, V-domain order, Fc).
Learn More
Automating Cell Therapy R&D
Streamline cell therapy R&D with purpose-built tools for designing and evaluating large panels of cell-based therapeutic modalities for novel immunotherapies.
By integrating directly with laboratory equipment, Genedata Biologics fully automates sample handling and testing procedures. The platform supports screening and engineering of diverse formats, including chimeric antigen receptor T cells (CAR-T), T cell receptor technologies (TCRs), and antibody TCR-mimetics (e.g., dsTCR, TCR-scFv, bispecific TCRs).
Learn More
Streamlining Gene Therapy Workflows
Accelerate gene therapy R&D by supporting the entire workflow, from serotype optimization and viral vector design to virus packaging, purification, and testing.
Genedata Biologics tracks all samples and associated data, including custom vectors, packaging plasmids, cell lysates, purified virus batches and their sequences, titers, and assay results such as empty-to-full capsid ratios. The platform also supports diverse viral delivery systems, including AAV, adenovirus, and retrovirus vectors.
Learn More
Enhancing ADC Discovery and Development
Register and track large panels of Antibody-Drug Conjugates (ADC) candidates while managing linker and payload data (e.g., cytotoxic small molecules) in a single integrated platform that combines analytics and functional assay results.
Genedata Biologics streamlines the entire ADC discovery process — from antibody screening and engineering to expression, purification, drug conjugation, and reporting of ADC metrics such as DAR, drug distribution, and homogeneity.
Learn More
Accelerating Vaccine Development
Streamline novel vaccine discovery by improving efficiency, speeding up testing, simplifying production, ensuring quality, and reducing costs.
Genedata Biologics supports emerging vaccine technologies such as synthetic self-amplifying mRNA, enabling faster development through cell-free processes and rapid antigen production, alongside traditional vaccine R&D.
Learn More
Transforming RNA Therapeutics
Revolutionize the end-to-end design and development of RNA therapeutics and vaccines with a platform that registers, tests, and evaluates nucleic acid-based candidates at every stage, covering RNA/DNA optimization for effectiveness and stability.
Paired with advanced screening workflows for formulation development and functional characterization, Genedata Biologics delivers a critical data infrastructure that enables faster RNA therapeutic development.
Learn More
Streamlining B-Cell-Derived Therapeutic Antibody Discovery
Facilitate B cell-derived therapeutic antibody R&D by streamlining every stage of the complex B cell-based discovery process. Genedata Biologics tracks animal and immunization data and registers molecules, samples, quality control, and functional assay results in a centralized platform.
ELISA, FACS, and SPR experiments are managed within the platform. When combined with V-region sequencing data, this enables integrated analysis of molecular sequences and functional performance.
Mitigating Developability Risks
Minimize developability and manufacturability risks by systematically assessing each candidate’s risk profile and critical quality attributes (CQA) to identify the most promising ones for development.
Genedata Biologics evaluates manufacturability by flagging potential issues during expression and purification and assessing properties that affect molecular robustness at the biophysical and biochemical level.
Learn MoreDiscover Genedata Biologics
High-Throughput Screening for Biotherapeutic Discovery
Designed for fully automated, high-throughput screening of biotherapeutic candidates, the software captures, integrates, processes, and interprets selection and screening data from diverse discovery technologies, including phage and yeast display, B-cell cloning, and hybridoma.
Built-in sample tracking and integrated plate management significantly improve the efficiency of early discovery workflows for antibodies, bi- and multi-specifics, fusion proteins, TCRs, CAR-Ts, and other emerging modalities.
Learn More
Protein Engineering and Optimization
The software enables efficient engineering of virtually any protein format and supports the generation of combinatorial libraries from known molecular building blocks. Built-in tools facilitate the design and optimization of IgGs and complex next-generation antibody formats, such as bi- and multi-specifics.
It supports simultaneous optimization of candidate properties — including binding affinity, cross-reactivity, stability, expressibility, and other critical attributes. Advanced tools for affinity maturation, site-directed mutagenesis, germlining, humanization, reformatting, and isotype switching enable rapid and reliable generation of optimized protein variants.
Learn More
Protein Production and Quality Control
To increase efficiency across the entire protein production process, the software tracks and validates each step, from initial protein definition to final, fully characterized high-quality samples. This includes all expression and purification batches, as well as vector and cell line batches.
Analytical characterization and QC data — including LC-MS, SEC, HIC, endotoxin levels, glycosylation profiles, and in vivo assay results — are aggregated and directly linked to their respective samples. Certificates of Analysis (CoAs) and other relevant reports are automatically generated using built-in tools.
Improving R&D Efficiency with Unified Task Management
The software enhances operational efficiency and oversight of R&D activities by supporting the full lifecycle of task scheduling. It manages request submission and tracking from initiation through completion, facilitates intra- and intergroup communication, and centrally documents request progress in real time.
Learn More
Centralized Tracking and Lifecycle Management
The software provides a fully integrated solution for managing samples — from cell banks and plasmids to proteins and complex mixtures. It centralizes inventory control, sample tracking, and workflow automation, delivering complete visibility into each sample’s lifecycle.
By linking samples directly to analytics, assay results, and QC data, the platform enables end-to-end traceability. Automated storage management, real-time occupancy dashboards, and barcode-based identification streamline handling, while audit-ready logs and version histories support regulatory compliance.
Learn More
Meet BIOLOGICS Customers
From enterprise-wide deployments to single-group installations, discover how Genedata Biologics helps leading global biopharma, biotechs, CROs, and CRDMOs increase efficiency and drive innovation.
Learn How We Support Biotherapeutics Discovery
End-to-End. A Next-Generation Platform.
Acting as a central, end-to-end data backbone, Genedata Biologics integrates all R&D processes — from library design and immunizations, selections and panning, molecular biology, screening, protein engineering, expression, purification, and analytics to candidate developability and manufacturability assessments. Its scalable, modular architecture fully automates the discovery process and handles high data volumes with ease. As a shared platform, it supports collaboration across sites, teams, and external partners such as CROs. Real-time access to relevant data empowers users at all levels to make informed decisions and uncover insights that drive future discovery programs.
Less Tedious Daily Work.
More Innovation.
Genedata Biologics simplifies daily lab activities — including cloning, screening, expression, purification, and sample management — and automates data upload, processing, and reporting. Direct integration with lab instruments and robotics enables true high-throughput workflows. Customers report over 50% gains in efficiency and improved data quality.
Optimize Resources. Increase Productivity. Eliminate Risks.
As a central, shared platform, Genedata Biologics gives R&D teams access to all discovery program data, across any project, at any time. This enables cross-project investigation, real-time progress tracking, and optimized resource usage to improve forecasting, reduce costs, and boost overall productivity.
Why Choose Genedata Biologics for Biotherapeutics Discovery?
Genedata Biologics is the leading platform for biopharma companies seeking to streamline biologics R&D through scalable, automated, and fully integrated workflows. Purpose-built for biotherapeutics discovery and development, it delivers immediate value and connects seamlessly with existing systems to eliminate data silos, democratize data, and accelerate innovation.
Its flexible architecture supports customization, enabling biopharma organizations to align workflows with diverse therapeutic pipelines and organizational requirements, ensuring scalability and efficiency across teams. By combining domain-specific functionality with intuitive design, Genedata Biologics drives superior efficiency, collaboration, and speed. It outperforms generic lab software and empowers teams to bring therapies to market faster.
- Increases Research Efficiency
- Streamlines Collaboration Across Teams
- Accelerates Time to Market
- Mitigates Risk and Supports Compliance
Genedata Biologics transforms biotherapeutics R&D by automating repetitive tasks and integrating diverse data sources into a single, streamlined platform. From high-throughput screening to protein engineering, it removes manual data handling and accelerates discovery workflows, allowing scientists to focus on innovation. By reducing operational overhead, Genedata Biologics shortens development timelines and boosts productivity.
Built for cross-functional collaboration, Genedata Biologics brings together scientists, analysts, and project managers in a shared digital workspace. The platform centralizes experimental data, protocols, and results, making them easily accessible and traceable across departments. This fosters transparency, improves decision-making, and keeps teams aligned throughout the biologics development lifecycle.
By integrating key R&D processes and automating critical steps, Genedata Biologics helps biopharma organizations to bring therapies to market faster. It eliminates bottlenecks in data processing and workflow execution, enabling rapid iteration and scale-up. By aggregating and linking experimental data across workflows, the platform reduces decision time and improves decision-making. With the ability to manage complex biologics workflows, Genedata Biologics ensures that promising candidates move efficiently from discovery to development.
Genedata Biologics reduces risks associated with data inconsistencies, regulatory non-compliance, and batch failure. Built-in tools for audit trails, data validation, and regulatory documentation support compliance with industry standards and best practices. This ensures robust, reproducible results and minimizes delays caused by quality or regulatory issues.
